Cue Health (HLTH)

Cue Health (HLTH)

IPO Stage

Empowering people to live their healthiest lives

Empowering people to live their healthiest lives


Funding data not publicly available

IPO Stage



IPO Date

Not Provided

Method of Going Public


Expected Public Exchange


Price Range

$15 - $17

Security Type

Equity - Common


Series C

SEC Filing Type

S-1    Open SEC Filing

IPO Valuation


IPO Lead Underwriter

Goldman Sachs, Morgan Stanley, Cowen

# of Acquisitions


Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



San Diego, California

Business Type


Cue Health, with an unknown public market valuation, is going public September 24th, 2021. The company is the developer and manufacturer of several products including its COVID-19 test kit and its Cue Health Monitoring System. Ayub Khattak and Clint Sever founded Cue Health in 2010. The medical technology company will trade under the ticker "HLTH" on the Nasdaq and is offering 12.5 million shares at a price range of $15 - $17.

Income Statement



Operating Expenses

Research/Technology & Development


Sales & Marketing


General & Administrative


Total Operating Expenses


Operating Income


Other Income, Net


Income (Loss) Before Provision For (Benefit From) Income Taxes


Provision For (Benefit From) Income Taxes


Net Income (Loss)



Net Income (Loss) Attributable to Common Stockholders:





Net Income (Loss) Per Share Attributable to Common Stockholders:





Weighted-Average Shares of Common Stock Used For Pro Forma:





Balance Sheet - Assets

Current Assets

Cash and Cash Equivalents


Accounts Receivable


Total Current Assets


Property and Equipment, Net




Intangible Assets, Net


Restricted Cash


Other Assets


Total Assets


Balance Sheet - Liabilities

Current Liabilities

Accounts Payable


Accrued Expenses


Other Current Liabilities


Total Current Liabilities


Total Liabilities


Commitments and Contingencies

Convertible Preferred Stock


Stockholders' (deficit) Equity

Common Stock


Additional Paid In Capital


Accumulated Other Comprehensive Income (Loss)


Total Stockholders' (Deficit) Equity


Statements of Cash Flows

Cash Flows from Operating Activites

Net Cash Provided By (Used In) Operating Activities


Cash Flows from Investing Activites

Net Cash Provided By (Used In) Investing Activities


Cash Flows from Financing Activites

Net Cash Provided By (Used In) Financing Activities


Total Cash, Cash Equivalents, and Restricted Cash


Financials as of: 09/01/2021
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Cue Health IPO 2021: A Startup Investor’s Guide
Platform: Robinhood
Security Type: Equity - Common
Valuation: $2,300,000,000

Follow company

Follow Cue Health IPO 2021: A Startup Investor’s Guide

Buy Cue Health's Deal Report

Warning: according to the close date for this deal, Cue Health may no longer be accepting investments.

Cue Health Deal Report

Get KingsCrowd’s comprehensive report on Cue Health including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Cue Health is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Cue Health deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge